News & Events
News articles, press releases and events Innoblative is attending
Committed to innovative surgical solutions for improved tissue coagulation and ablation, enhancing patient care.
News & Press Releases
AMA Approves Category III CPT® Code for Innoblative’s SIRA® RFA Electrosurgical Device, an Adjunct for Patients Undergoing Breast Conservation Surgery
CHICAGO, March 3, 2026 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has received Category III Current Procedural Terminology (CPT®) approval from the American Medical Association (AMA) for
Innoblative Receives U.S. IDE Approval for its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, April 10, 2025 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that the U.S. Food and Drug Administration has approved its Investigational Device Exemption (IDE) application, paving the
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has initiated its first-in-human clinical experience, successfully treating a 64-year-old patient with stage II luminal A
Innoblative Designs: Revolutionizing Post-Lumpectomy Treatment
July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins post-excision for treating early-stage breast cancer. Developed by a team of surgeons and graduate students at Northwestern University, our SIRAT™
Innoblative Receives U.S. FDA Breakthrough Device Designation for its SIRA RFA Electrosurgical Device
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it received Breakthrough
Innoblative Welcomes Kelly Londy as Chief Executive Officer
CHICAGO, Sept. 4, 2019 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-energy surgical solutions, including its recently FDA cleared SIRA™ RFA Electrosurgical Device, today announced the appointment of Kelly Londy as Chief Executive Officer. “We are delighted to
Upcoming & Past Events
LSI USA ’26 — Emerging Medtech Summit
When: March 16–20, 2026 Location: Dana Point, California Details:LSI USA ’26 brings the global medtech community to Dana Point for a week of focused conversations
EBCC-15 — European Breast Cancer Conference
When: March 25–27, 2026 Location: Florence, Italy Find Us: Booth 12 Details: The 15th European Breast Cancer Conference brings together the continent’s leading clinicians, researchers,
ASBrS 2026 — 27th Annual Meeting of The American Society of Breast Surgeons
When: April 29–May 3, 2026 Location: Seattle Convention Center, Seattle, Washington, USA Booth Number: 424 Details:ASBrS 2026 brings together leaders in breast surgery and multidisciplinary
LSI Europe ’25 — Emerging Medtech Summit
When: September 7–11, 2025 Location: JW Marriott Grosvenor House, London, United Kingdom Details:Join us at LSI Europe ’25 — Emerging Medtech Summit, the global forum
The MedTech Conference 2025 (AdvaMed)
When: October 5–8, 2025 Location: San Diego, California Details:Join thousands of medtech leaders at The MedTech Conference 2025, the premier U.S. event uniting executives, innovators,
ESSO 44 — European Society of Surgical Oncology Congress
When: October 15–17, 2025 Location: Gothia Towers, Swedish Exhibition & Congress Centre, Gothenburg, Sweden Details:Be part of the 44th Congress of the European Society of